Nutex Health (NASDAQ:NUTX) Trading Down 4.4% - Here's Why

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) traded down 4.4% on Tuesday . The stock traded as low as $160.08 and last traded at $160.63. 16,904 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 69,988 shares. The stock had previously closed at $167.96.

Wall Street Analysts Forecast Growth

NUTX has been the topic of a number of recent research reports. Wall Street Zen cut Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd. Benchmark raised their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Finally, Maxim Group upped their target price on shares of Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a report on Tuesday, May 20th.

Nutex Health Stock Performance

The firm has a market capitalization of $679.16 million, a PE ratio of -13.00 and a beta of 0.04. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The company has a 50-day moving average of $131.62 and a 200 day moving average of $73.95.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, topping the consensus estimate of ($0.15) by $2.71. The company had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insider Buying and Selling

In related news, CFO Jon Christian Bates acquired 1,000 shares of Nutex Health stock in a transaction dated Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the completion of the purchase, the chief financial officer now owns 4,888 shares of the company's stock, valued at $399,887.28. This represents a 25.72% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 38.52% of the stock is owned by company insiders.

Hedge Funds Weigh In On Nutex Health

A number of large investors have recently bought and sold shares of the stock. Topline Capital Management LLC bought a new position in shares of Nutex Health in the fourth quarter worth approximately $5,690,000. American Century Companies Inc. bought a new stake in Nutex Health in the 4th quarter worth $1,362,000. Ancora Advisors LLC purchased a new position in shares of Nutex Health in the fourth quarter valued at about $1,334,000. Essex Investment Management Co. LLC increased its position in shares of Nutex Health by 45.4% in the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after acquiring an additional 33,024 shares during the period. Finally, Russell Investments Group Ltd. bought a new position in shares of Nutex Health during the fourth quarter valued at about $672,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.